Russell Investments Group Ltd. Acquires 45,711 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Russell Investments Group Ltd. grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 5.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 900,306 shares of the medical instruments supplier's stock after buying an additional 45,711 shares during the period. Russell Investments Group Ltd. owned 0.42% of DENTSPLY SIRONA worth $32,042,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. VisionPoint Advisory Group LLC boosted its holdings in DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier's stock valued at $26,000 after acquiring an additional 395 shares during the period. Headlands Technologies LLC purchased a new stake in DENTSPLY SIRONA in the 4th quarter valued at approximately $30,000. Parkside Financial Bank & Trust increased its position in DENTSPLY SIRONA by 33.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier's stock worth $42,000 after buying an additional 292 shares in the last quarter. Anchor Investment Management LLC purchased a new position in DENTSPLY SIRONA in the 4th quarter valued at about $47,000. Finally, Exchange Traded Concepts LLC grew its holdings in shares of DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier's stock worth $51,000 after buying an additional 439 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of XRAY traded up $0.17 on Wednesday, reaching $30.18. 2,453,254 shares of the stock traded hands, compared to its average volume of 3,288,782. DENTSPLY SIRONA Inc. has a 12 month low of $26.27 and a 12 month high of $43.24. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The firm has a market cap of $6.26 billion, a price-to-earnings ratio of -48.68, a P/E/G ratio of 1.24 and a beta of 0.98. The stock's 50-day moving average price is $32.34 and its 200-day moving average price is $32.76.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping the consensus estimate of $0.43 by $0.01. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $972.61 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. DENTSPLY SIRONA's revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.46 EPS. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Wednesday, March 27th. This is a positive change from DENTSPLY SIRONA's previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a yield of 2.12%. DENTSPLY SIRONA's payout ratio is currently -103.22%.

Analyst Ratings Changes

Several analysts have commented on XRAY shares. SVB Leerink began coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They issued an "outperform" rating and a $42.00 price target for the company. Leerink Partnrs restated an "outperform" rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Barrington Research restated an "outperform" rating and issued a $41.00 target price on shares of DENTSPLY SIRONA in a report on Thursday, April 18th. Piper Sandler boosted their price target on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a "neutral" rating in a report on Friday, January 12th. Finally, StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, January 19th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $39.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.